Oct Ophthalmoscope

Introducing a compact instrument that combines automated OCT, true color fundus photography, and automated OCT Angiography. Our world-renowned, multi-modal OCT solution, OCTA, provides you with instantaneous vascular structure information with the simple press of a button.



The NHS DES Programme has been approved.

The Maestro 2 has been approved for inclusion in the camera list of the NHS Diabetic Eye Screening Programme.

The DES Programme is a valuable annual eye screening service that is beneficial for detecting early changes in the eye caused by diabetes. It is a valuable resource for many of our patients. Fundus photography is used to conduct this screening.input:
output:
User-friendly

An OCT that is user-friendly. The Maestro2 enhances practice efficiency and delivers optimal patient care by utilizing robotic technology.



Capture that is entirely automated

With a single touch, the Maestro2 executes alignment, focus, optimization, and capture automatically. The report can be accessed immediately by clicking on the icon following the capture of the image. input:
output:Manual/Semi-Automatic Capture

The Maestro2 provides manual/semi-auto options for patients who are challenging to image in addition to automated capture.input:
output:
Widefield optical coherence tomography (OCT

The Maestro2 is capable of capturing a widefield OCT scan that spans 12mm x 9mm, which includes both the macula and optic disc. The scan is particularly well-suited for an annual eye exam, as it minimizes the time required for patient testing. It includes a Glaucoma report that includes disc topography, as well as thickness and reference data for the retina, RNFL, and ganglion cell layers.input:
output:GCL+: The thickness of GCL and IPLGCL++: The thickness of the RNFL, IPL, and GCLinput:
output:Please be advised that not all products, services, or offers are approved or available in every market, and the availability of products may differ from one country to another. For country-specific information, please reach out to us.